Company page
Medite Cancer Diagnostics Inc
Medite Cancer Diagnostics Inc (MDIT) is a public company based in the United States, focused on developing innovative diagnostic solutions for cancer detection. With a market capitalization of approximately $8.62 billion, Medite aims to improve patient outcomes through advanced technology and research in the field of cancer diagnostics. The company is committed to providing reliable and accurate diagnostic tools to healthcare professionals.

- Ticker
- MDIT
- Market cap
- $8,620
- Sector
- Health Technology
- Industry
- Medical Specialties